SCHEMBL6647148

SCHEMBL6647148

CC(C)Nc1ncc[nH]c1=O

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 5/20 0.40
LRRK2 Q5S007 2/20 0.39
FDPS P14324 1/20 0.36
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 1/20 0.33
TXN P10599 1/20 0.32
TXNRD1 Q16881 1/20 0.32
PDE10A Q9Y233 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.31
JAK1 P23458 1/20 0.31
FFAR2 O15552 1/20 0.31
FPR2 P25090 1/20 0.31
SYK P43405 2/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10574839 0.78
SCHEMBL2787025 0.74
Hydrochloric Acid SCHEMBL2699935 0.72 ALDH1A1 (0.33) FDPSALDH1A1SMN1; SMN2
SCHEMBL7556283 0.72 GDA (0.40) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL2625552 0.71
SCHEMBL2787049 0.71 ALDH1A1 (0.32) FDPSALDH1A1SMN1; SMN2
SCHEMBL2633430 0.69 ALDH1A1 (0.39) FDPSALDH1A1SMN1; SMN2KDM4ETXN
SCHEMBL22408544 0.69 CASP6 (0.47) LRRK2ALDH1A1SMN1; SMN2KDM4ETRPM8
SCHEMBL7872469 0.69 TAAR1 (0.41) JAK2JAK1
SCHEMBL10072452 0.69 LRRK2 (0.44) LRRK2FDPSSMN1; SMN2PDE10ATRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1448534-A1 6-MEMBERED UNSATURATED HETEROCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OFTHE COAGULATION CASCADE Pharmacia Corporation (US) 2004-08-25 EP disclosed
WO-2003029224-A1 6-MEMBERED UNSATURATED HETEROCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2003-04-10 WO disclosed